Aveanna Healthcare
AVAH
12.35
+0.04
+0.32%
Aveanna Healthcare
US · AVAH
#2572 by market cap
Listed 2021
12.35
+0.04
+0.32%
Live - 5344 symbols - heartbeat 566s ago
· 2026-10-08 10:00
Pre-market
12.56
+2.03%
After-hours
12.87
+4.54%
- Market cap
- 2.70B
- P/E (TTM)i
- 9.80
- P/Bi
- 9.36
- EPSi
- 1.05
- Div yieldi
- 0.00%
- 52W posi
- 73%
Reader sentiment
Are you bullish or bearish on AVAH?
Anonymous reader poll. Unscientific, not investment advice.
Analyst consensus 7 analysts
Buy
Avg price target
15.00 +21.5%
Price target rangecurrent 12.35
Low14.00
Avg15.00
High16.00
Buy 71%
Hold 29%
Sell 0%
Recent ratings (25)
| Date | Firm | Analyst | Rating | Target |
|---|---|---|---|---|
| 2026-09-28 | Raymond James | -- | BUY | 15.00 |
| 2026-09-25 | Barclays | -- | BUY | 15.00 |
| 2026-09-14 | J.P. Morgan | -- | HOLD | 15.00 |
| 2026-08-28 | Barclays | -- | BUY | 15.00 |
| 2026-08-24 | Truist Financial | -- | HOLD | 15.00 |
| 2026-08-21 | RBC Capital | -- | BUY | 16.00 |
| 2026-08-14 | Truist Financial | -- | HOLD | -- |
| 2026-08-14 | BMO Capital | -- | BUY | 14.00 |
| 2026-08-13 | William Blair | -- | BUY | -- |
| 2026-07-14 | Truist Financial | -- | HOLD | 11.00 |
| 2026-06-12 | William Blair | -- | BUY | -- |
| 2026-06-03 | RBC Capital | -- | BUY | 10.00 |
| 2026-06-02 | William Blair | -- | BUY | -- |
| 2026-05-18 | Barclays | -- | BUY | 9.00 |
| 2026-05-15 | Stephens | -- | BUY | 11.00 |
| 2026-05-15 | BMO Capital | -- | BUY | 10.00 |
| 2026-05-15 | Barclays | -- | BUY | 9.50 |
| 2026-05-14 | William Blair | -- | BUY | -- |
| 2026-05-14 | RBC Capital | -- | HOLD | 10.00 |
| 2026-03-27 | J.P. Morgan | -- | HOLD | 8.00 |
| 2026-03-25 | Barclays | -- | BUY | 9.50 |
| 2026-03-20 | William Blair | -- | BUY | 6.57 |
| 2026-03-20 | Raymond James | -- | BUY | 13.00 |
| 2026-03-20 | Jefferies | -- | BUY | 10.00 |
| 2026-03-20 | BMO Capital | -- | BUY | 10.00 |
Quant vs Street three independent views, side by side
Momentum strategy signal
Buy
Analyst consensus
Buy
All 2 views agree: bullish.
Not investment advice. The factor grade ranks this stock on fundamentals against StockVane's covered universe; the momentum strategy signal is a rules-based backtest, not a recommendation; analyst consensus reflects sell-side coverage. The three use different methods and can reasonably disagree.
Price target trend monthly average, last 3 years
✦ Quant Analyst Revision Trend how this is computed
Mixed
1
■ Upgrades■ Downgrades
- 1 upgrade vs 0 downgrades among tracked analyst rating changes.
- Most recent: RBC Capital moved from Hold to Buy on 2026-06-03.
Recent rating changes
| Date | Firm | Change | Target |
|---|---|---|---|
| 2026-06-03 | RBC Capital | HOLD → BUY | 10.00 |
Earnings history price reaction on the day
| Period | Report date | Session | Options expected | Actual move |
|---|---|---|---|---|
| 2026/Q2 | 2026-08-13 | -- | ±17.11% | +24.75% (beat) |
| 2026/Q1 | 2026-05-14 | -- | ±13.29% | +9.90% (in line) |
| 2025/Q4 | 2026-03-19 | -- | ±17.37% | -8.25% (in line) |
| 2025/Q3 | 2025-11-06 | -- | ±25.78% | -6.30% (in line) |
| 2025/Q2 | 2025-08-07 | -- | -- | +49.36% |
| 2025/Q1 | 2025-05-08 | -- | ±17.63% | +14.11% (in line) |
| 2024/Q4 | 2025-03-13 | -- | ±73.53% | +37.43% (in line) |
| 2024/Q3 | 2024-11-07 | -- | ±23.49% | +16.22% (in line) |
| 2024/Q2 | 2024-08-08 | -- | ±69.97% | +32.22% (in line) |
| 2024/Q1 | 2024-05-09 | -- | ±16.53% | +2.48% (in line) |
| 2023/Q4 | 2024-03-14 | -- | ±12.00% | -3.00% (in line) |
| 2023/Q3 | 2023-11-09 | -- | ±104.70% | +2.01% (in line) |
"Options expected" is the pre-earnings options market's implied move (a straddle-style estimate), shown next to what actually happened.
Quote time 2026-10-08 10:00:13 · For reference only, not investment advice and not tailored to your situation.